- RFK Jr. removes all members of CDC panel advising U.S. on vaccineson June 9, 2025 at 8:53 pm
It's the latest move by Kennedy – a prominent vaccine skeptic – to change and potentially undermine vaccinations in the U.S. since he took the helm at HHS.
- FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZenecaon June 9, 2025 at 8:13 pm
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
- Omada shares rise 21% in Nasdaq debut after health tech company's IPOon June 6, 2025 at 8:18 pm
Omada Health became the latest tech company to hit the Nasdaq on Friday, as the IPO market picks up steam.
- Omada Health prices IPO at $19 per share, in middle of expected rangeon June 6, 2025 at 11:33 am
Omada Health is set to start trading on the Nasdaq, hitting the market a few weeks after Hinge Health, another emerging company in the space.
- How twin sister triathletes doubled down on sports success to raise health-startup millions from investorson June 5, 2025 at 4:58 pm
Michal and Merav Mor, twin sister triathletes and PhDs, turned a quest for fitness excellence into metabolic device startup Lumen, and it's raised millions.
- It's not just AI — China's quickly gaining an edge over the U.S. in biotechon June 5, 2025 at 12:10 pm
For all the attention on U.S.-China AI competition, new studies point to China's rapid rise in biotechnology, especially for drug and agricultural development.
- Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCOon June 4, 2025 at 4:37 pm
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.
Click Advertiser ♥
-
-
-
-